Pfizer asks FDA to authorize third dose for children 5 to 11 years old

Sandra Hughes prepares to give the first dose of Pfizer-BioNTech coronavirus (COVID-19) vaccine to Elise Langevina, 6, in Storrs, Connecticut, U.S., November 3, 2021.

Michelle McLoughlin | Reuters

Pfizer on Tuesday asked the Food and Drug Administration for permission to give a third dose of the Covid vaccine to children aged 5 to 11.

The application comes after Pfizer released clinical trial data earlier this month showing that blood samples from 30 children in this age group had a 36-fold increase in antibody levels against the omicron variant compared with two doses of the vaccine. .

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest news on the Covid pandemic:

Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button